A high or borderline eGFR is usually a calculation issue or a normal finding, not kidney failure. The useful interpretation comes from creatinine, urine albumin, glucose, blood pressure, age, and the direction of change over time.
This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review by Dr. Sarah Mitchell, MD, PhD.
Thomas Klein, MD
Chief Medical Officer, Kantesti AI
Dr. Thomas Klein is a board-certified clinical hematologist and internist with over 15 years of experience in laboratory medicine and AI-assisted clinical analysis. As Chief Medical Officer at Kantesti AI, he provides clinical oversight of the medical accuracy of the proprietary neural network. Dr. Klein has published on biomarker interpretation and laboratory diagnostics.
Sarah Mitchell, MD, PhD
Chief Medical Advisor - Clinical Pathology & Internal Medicine
Dr. Sarah Mitchell is a board-certified clinical pathologist with over 18 years of experience in laboratory medicine and diagnostic analysis. She holds specialty certifications in clinical chemistry and has published extensively on biomarker panels and laboratory analysis in clinical practice.
Prof. Dr. Hans Weber, PhD
Professor of Laboratory Medicine & Clinical Biochemistry
Prof. Dr. Hans Weber brings 30+ years of expertise in clinical biochemistry, laboratory medicine, and biomarker research. Former President of the German Society for Clinical Chemistry, he specializes in diagnostic panel analysis, biomarker standardization, and AI-assisted laboratory medicine.
- Borderline eGFR meaning: An eGFR of 90 mL/min/1.73 m² or higher is not chronic kidney disease unless urine, imaging, or other evidence shows kidney damage for at least 3 months.
- High eGFR: A result of 100-120 mL/min/1.73 m² is often normal in a younger adult and is not, by itself, evidence of kidney failure.
- Hyperfiltration threshold: Persistent eGFR above roughly 135 mL/min/1.73 m² can suggest hyperfiltration, but no single cutoff applies to every age, sex, or laboratory.
- Low muscle mass: Low creatinine from small body size, frailty, muscle loss, vegetarian eating, or pregnancy can make creatinine-based eGFR look higher than true filtration.
- ACR companion test: A urine albumin-to-creatinine ratio below 30 mg/g is normal; 30-300 mg/g is moderately increased albuminuria and changes a high-eGFR interpretation.
- Diabetes clue: High eGFR plus raised fasting glucose, HbA1c, or urine albumin deserves follow-up because early diabetes can cause glomerular hyperfiltration.
- Best confirmation: Cystatin C-based eGFR is especially useful when creatinine may be misleading because of unusual muscle mass, diet, amputation, or chronic illness.
- Urgent symptoms: A high eGFR does not cause emergency symptoms, but swelling, breathlessness, markedly reduced urine, visible blood in urine, or severe hypertension need prompt clinical assessment.
What a borderline or high eGFR usually means
Borderline eGFR meaning is usually reassuring when the result is 90 mL/min/1.73 m² or higher and urine testing is normal. A high estimated GFR does not mean the kidneys are failing; it commonly reflects a low creatinine concentration, younger age, pregnancy, or genuinely efficient filtration. As of September 21, 2026, clinicians diagnose chronic kidney disease from an eGFR below 60 for 3 months or more, or from persistent markers of kidney damage—not from eGFR being high.
eGFR is an estimate, not a direct measurement. The laboratory enters serum creatinine, age, and sex into an equation, then reports filtration standardized to 1.73 m² of body surface area; it does not count individual nephrons. Kantesti is an AI blood test analyzer that reads eGFR alongside creatinine, urine markers, and the broader metabolic panel rather than treating one flag as a diagnosis.
A laboratory may display “>90” or “>60” rather than a precise high number because creatinine equations become less accurate at higher filtration rates. The 2024 KDIGO guideline classifies eGFR of 90 or above as G1, which is normal or high; G1 alone is not CKD (KDIGO, 2024).
In my clinical work, the anxious calls often come from people seeing eGFR 118 beside a low-normal creatinine of 0.58 mg/dL. In a healthy 29-year-old with normal blood pressure and a negative urine albumin test, that pattern is far more often physiology than disease; our biomarker guide explains why reference flags need context.
The phrase “borderline” can mislead
A borderline flag can be a laboratory display convention rather than a medical threshold. eGFR varies by about 5-10% from biological fluctuation and assay variation, so a single isolated result should not be used to label someone with kidney disease or hyperfiltration.
Why creatinine can make eGFR look unexpectedly high
A slightly elevated eGFR most often occurs because serum creatinine is lower than the equation expects for a person of that age and sex. Creatinine is produced by skeletal muscle and cleared by kidneys, so the same filtration rate can generate very different eGFR values in a bodybuilder and a small older adult.
The 2021 CKD-EPI creatinine equation removed race from eGFR reporting and uses age and sex alongside creatinine. Inker and colleagues found the new creatinine-cystatin C equation was more accurate than creatinine alone, particularly when precision matters (Inker et al., 2021). See our practical BUN and creatinine guide for why these two values answer different questions.
A serum creatinine of 0.50 mg/dL may produce eGFR above 120 mL/min/1.73 m² in an adult, but the number can overestimate filtration in sarcopenia, neuromuscular disease, cirrhosis, limb amputation, or substantial recent weight loss. High protein intake and creatine supplements usually push creatinine upward, which lowers calculated eGFR—the opposite direction.
Kantesti AI is an AI blood test interpretation platform that identifies when a creatinine-based estimate conflicts with weight change, CBC clues, liver markers, or prior results. That mismatch is a prompt for confirmation, not a reason to self-diagnose kidney damage.
Is eGFR of 100, 110, or 120 normal for your age?
An eGFR of 100-120 mL/min/1.73 m² is commonly normal in younger adults, whereas the expected average declines gradually with age. eGFR naturally falls from roughly 120 mL/min/1.73 m² in early adulthood by about 0.75-1 mL/min/1.73 m² per year after age 40, although individual variation is wide.
There is no universal “too high” range printed on every report. A value of 108 in a 25-year-old can be ordinary, while an abrupt rise from 72 to 110 in a 70-year-old should first make us check creatinine calibration, hydration, illness, and loss of muscle rather than assume healthier kidneys.
Body surface area adjustment matters. eGFR is normalized to 1.73 m², so in a very small or very large person, the reported value may differ materially from absolute filtration in mL/min; nephrologists may calculate non-indexed GFR for chemotherapy dosing or living-donor assessment.
If your eGFR is high but stable, record the actual creatinine value and date of each test. Trend review is more useful than comparing your number with a fit 22-year-old; longitudinal lab analysis can help preserve that context.
When high eGFR can indicate glomerular hyperfiltration
High eGFR becomes more clinically relevant when it is persistent, usually above about 135 mL/min/1.73 m², and occurs with diabetes, albumin in urine, obesity, or high blood pressure. This pattern is called glomerular hyperfiltration, but the cutoff is debated because age, body size, and the estimating equation alter the result.
Hyperfiltration means individual glomeruli filter unusually large volumes, often because intraglomerular pressure is elevated. It can precede later eGFR decline in type 1 and type 2 diabetes, but a creatinine-based eGFR above 135 alone does not prove that physiology; Tonneijck et al. describe this uncertainty clearly in their 2017 CJASN review.
The combination that concerns me is eGFR 138, HbA1c 7.4%, blood pressure 146/92 mmHg, and ACR 85 mg/g. By contrast, eGFR 138 with HbA1c 5.1%, ACR 5 mg/g, and a creatinine of 0.48 mg/dL in a lean young adult may simply be imprecision in the estimate; CKD stages and ACR put these categories together.
Kantesti AI flags persistent high-filtration patterns for clinician discussion when companion markers point the same way. Thomas Klein, MD, advises patients not to chase a lower eGFR number with dehydration, fasting, or unnecessary supplements—those tactics only distort the test.
The companion results that change a high eGFR interpretation
Urine albumin-to-creatinine ratio, urinalysis, blood pressure, glucose, HbA1c, and creatinine trend are the results that determine whether a high eGFR needs attention. A normal eGFR cannot rule out early kidney damage when urine albumin is elevated.
An ACR below 30 mg/g (below 3 mg/mmol) is normal to mildly increased; 30-300 mg/g is moderately increased albuminuria, and above 300 mg/g is severely increased. A first-morning urine sample is preferable because exercise, fever, urinary infection, menstruation, and marked hyperglycaemia can cause transient albumin elevation.
Dipstick protein is less sensitive than ACR for early albuminuria, while red cells, casts, or persistent glucose in urine point to different renal questions. Our ACR preparation guide covers how to avoid a misleading collection.
Serum albumin, potassium, bicarbonate, urea/BUN, and blood pressure provide useful supporting evidence. An eGFR of 115 with normal ACR, potassium 4.2 mmol/L, bicarbonate 25 mmol/L, and stable creatinine has a very different meaning from the same eGFR with abnormal urine sediment.
Diabetes, glucose, and the high eGFR pattern
Diabetes is one of the best-established high eGFR causes because early hyperglycaemia can increase glomerular pressure and filtration. Persistent fasting glucose of 126 mg/dL or higher, HbA1c of 6.5% or higher, or diabetes symptoms should shift the focus from eGFR alone to metabolic and urine-kidney risk.
Early diabetic hyperfiltration may occur before creatinine rises, particularly in younger people with recently diagnosed diabetes. Tonneijck et al. reported that hyperfiltration is biologically plausible but difficult to define accurately with estimated GFR, which is why clinicians repeat tests and use urine albumin rather than making a diagnosis from one value.
An HbA1c of 5.7-6.4% indicates prediabetes, while 6.5% or above meets the laboratory criterion for diabetes when confirmed in an appropriate clinical setting. High triglycerides, central adiposity, and hypertension add risk; see high glucose warning signs if symptoms are present.
Kantesti is an AI-powered blood test analysis tool that interprets eGFR with HbA1c, glucose, triglycerides, and liver markers, because metabolic risk is a pattern rather than a single creatinine calculation.
Other high eGFR causes: pregnancy, diet, and physiology
Pregnancy, a recent high-protein meal, recovery from illness, and some medicines can raise measured or estimated filtration without indicating kidney failure. Pregnancy commonly increases true GFR by roughly 40-50% by the second trimester, so non-pregnant eGFR reference assumptions do not apply.
Most laboratories do not validate routine creatinine eGFR equations during pregnancy. A creatinine above about 0.9 mg/dL can be more concerning in pregnancy than it would be outside pregnancy, while a low creatinine may be entirely expected; our pregnancy GFR guide explains the safer approach.
High dietary protein can transiently raise actual GFR, but it rarely explains a striking eGFR result by itself. Non-steroidal anti-inflammatory medicines usually lower GFR in susceptible people, whereas SGLT2 medicines often produce a small initial eGFR dip that reflects a beneficial haemodynamic reset rather than injury; read about the SGLT2 eGFR dip.
A 52-year-old endurance athlete I reviewed had eGFR 124 after a large recovery shake and a low creatinine baseline. Her ACR was 4 mg/g and repeat fasting creatinine was unchanged—reassuring, but still worth documenting rather than calling it “super-kidneys.”
Low muscle mass and frailty can falsely elevate eGFR
Low muscle mass can make creatinine-based eGFR look higher than the kidney’s true filtration capacity. This is most relevant after unintentional weight loss, prolonged immobility, advanced liver disease, eating disorders, neuromuscular conditions, or in frail older adults.
Creatinine generation may fall before a patient or clinician notices visible muscle loss. A creatinine of 0.42 mg/dL in a thin 79-year-old recovering from a hospital stay can produce eGFR above 100, yet cystatin C may suggest lower filtration; this discrepancy is clinically meaningful for medication dosing.
Cystatin C is produced by most nucleated cells and is less dependent on muscle mass, although thyroid disease, corticosteroids, smoking, and systemic illness can affect it. A combined creatinine-cystatin C eGFR is generally the most reliable estimate when the two markers disagree, according to Inker et al. (2021).
Do not use a high eGFR to dismiss frailty or nutritional risk. A low cystatin C result has different implications from low creatinine, and the clinical history decides which marker deserves more weight.
How clinicians confirm whether a high eGFR is real
The best confirmation for an unexpectedly high eGFR is repeat creatinine with urine ACR, followed by cystatin C or measured GFR when the answer will change care. Repeating a stable outpatient test in 1-3 months is usually more informative than ordering urgent imaging for an isolated high result.
For a clean repeat, avoid unusually strenuous exercise for 24-48 hours, maintain ordinary hydration, and tell the clinician about creatine, trimethoprim, cimetidine, and recent illness. Exercise can raise creatinine through muscle release, whereas excessive water intake can dilute it slightly; neither produces a reliable “better” kidney result.
Cystatin C-based eGFR is particularly helpful when creatinine is below 0.6 mg/dL or clinical muscle mass is clearly atypical. Directly measured GFR using exogenous filtration markers is reserved for selected situations such as donor work-up, certain drug dosing decisions, and unresolved discordance.
Repeat urine results matter as much as repeat blood results. A urine creatinine review can explain why a spot ACR was unreliable when the sample was extremely dilute or concentrated.
When to worry about eGFR and seek medical care
A high eGFR itself is rarely urgent, but high eGFR with albuminuria, diabetes, uncontrolled blood pressure, blood in urine, or a fast creatinine change warrants medical review. New swelling, breathlessness, confusion, a major reduction in urine output, or blood-coloured urine should be assessed promptly regardless of the eGFR displayed.
Persistent blood pressure at or above 140/90 mmHg should trigger assessment, while 180/120 mmHg with chest pain, neurological symptoms, or breathlessness is an emergency. Kidney disease can be silent, so a normal or high eGFR never overrides substantial albuminuria or a concerning urine sediment.
A new ACR above 30 mg/g should usually be repeated to establish persistence, ideally after excluding urinary infection and heavy exercise. Visible blood in urine, especially with clots, flank pain, or fever, needs timely evaluation; our guide to blood in urine explains the usual pathway.
Thomas Klein, MD, has seen patients reassured too quickly by an eGFR of 95 despite ACR 600 mg/g. The kidney’s filtration rate and its barrier function are different jobs, so urine protein can be the earlier warning signal.
Why a high eGFR is not kidney failure
Kidney failure causes low filtration, not high eGFR; an eGFR below 15 mL/min/1.73 m² is the conventional threshold for kidney failure. The confusion happens because “out of range” on a report can sound dangerous even when the high direction is often benign.
An eGFR below 60 mL/min/1.73 m² for at least 3 months is one route to diagnosing CKD, and values below 30 merit more active evaluation and medication review. The symptoms people associate with renal failure—fluid retention, nausea, itch, fatigue, and reduced appetite—usually relate to advanced low filtration or another illness, not high eGFR.
Creatinine can rise temporarily after intense resistance exercise, dehydration, or a large cooked-meat meal, making eGFR appear lower. That counterpart is covered in our creatinine after exercise guide; it reinforces why one result should not be over-read.
A low eGFR and a high eGFR can both be inaccurate when creatinine is distorted. The right question is not “Which number is best?” but “Does the estimate fit the urine, symptoms, medicines, body composition, and prior baseline?”
Medication safety when eGFR seems unusually high
An unexpectedly high eGFR should not automatically be used to approve a higher medication dose, especially in older or low-muscle-mass adults. Drug dosing sometimes uses creatinine clearance by Cockcroft-Gault rather than lab-reported eGFR, and the two figures can differ substantially.
Antibiotics, metformin, lithium, direct oral anticoagulants, and some chemotherapy medicines have renal dose rules. For drug decisions, clinicians consider age, actual weight, creatinine trend, and the product label rather than relying on an eGFR above 90 as proof of normal clearance.
Trimethoprim and cimetidine can increase serum creatinine by reducing tubular secretion without reducing true GFR. Conversely, very low creatinine can hide impaired clearance in muscle wasting; lithium monitoring is a good example of why longitudinal renal data matter.
Never stop a prescribed medicine merely because eGFR is 125. Bring the full medication and supplement list to the prescriber, including creatine powders, anti-inflammatory pain medicines, and over-the-counter acid suppressants.
A practical retest plan for a borderline eGFR result
For an isolated high or borderline eGFR with no symptoms, repeat creatinine and urine ACR under usual conditions within 1-3 months. If diabetes, albuminuria, hypertension, pregnancy, or low muscle mass is present, arrange clinician review sooner and consider cystatin C.
Before the repeat, keep ordinary fluid intake, avoid a marathon or maximal gym session for 24-48 hours, and do not deliberately load protein or water. Record recent fever, vomiting, diarrhoea, medication changes, menstrual bleeding, and supplements—small details can explain apparent changes better than a new diagnosis.
Ask for creatinine, eGFR, urine ACR, urinalysis, blood pressure, fasting glucose or HbA1c when appropriate, and cystatin C if body composition makes creatinine unreliable. The basic metabolic panel guide helps you identify the supporting electrolytes and bicarbonate.
Most patients find a written two-date comparison more calming than a single reference flag. Kantesti’s trend analysis can organize that comparison, while our AI blood test benchmark describes how we assess consistency across complex lab reports.
What not to do after seeing a high eGFR flag
Do not restrict water, start kidney supplements, or change a prescribed drug simply to alter a high eGFR result. A high creatinine-derived estimate is not an instruction to treat the kidneys, and dehydration may temporarily lower eGFR while causing real harm.
“Kidney detox” products can contain concentrated herbs, stimulants, or minerals with uncertain safety and no evidence that they correct hyperfiltration. Protein restriction is not appropriate for everyone either; it can worsen nutrition in frail adults and should be individualized if CKD is actually present.
Do not diagnose proteinuria from foamy toilet water alone. Persistent foam can be worth testing, but urine concentration and cleaning products can create bubbles; use an ACR rather than visual inspection, as explained in our foamy urine guide.
A sensible next step is modest: verify the result, look for albuminuria, and address real drivers such as diabetes and blood pressure. The clinicians on our Medical Advisory Board support a safety-first approach in which AI interpretation complements—not replaces—individual clinical assessment.
Frequently Asked Questions
What does a borderline eGFR mean?
Borderline eGFR meaning depends on which side of the range is borderline. An eGFR of 90 mL/min/1.73 m² or higher is normal or high and does not indicate chronic kidney disease unless there is persistent kidney damage such as urine ACR of 30 mg/g or higher. An eGFR of 60-89 can also be normal in many adults when urine testing and imaging are normal. Chronic kidney disease generally requires eGFR below 60 for at least 3 months or another persistent marker of kidney damage.
Can eGFR be too high?
An eGFR above 100 or 120 mL/min/1.73 m² is often normal, particularly in younger adults, and is usually not dangerous by itself. Persistent values above about 135 mL/min/1.73 m² may reflect glomerular hyperfiltration, especially when diabetes, high blood pressure, obesity, or urine albumin is present. There is no universally accepted high-eGFR cutoff because creatinine equations are less precise at high filtration. Repeat creatinine, urine ACR, glucose testing, and sometimes cystatin C clarify whether a high result is meaningful.
What causes a slightly elevated eGFR?
Slightly elevated eGFR most commonly results from low serum creatinine due to smaller muscle mass, recent weight loss, pregnancy, younger age, or normal biological variation. Pregnancy can increase true GFR by approximately 40-50%, while frailty or muscle loss can falsely raise creatinine-based eGFR without increasing true filtration. Early diabetes can also cause hyperfiltration, particularly when eGFR is persistently above roughly 135 mL/min/1.73 m². A urine ACR below 30 mg/g and normal HbA1c make harmful hyperfiltration less likely.
Should I worry about eGFR 120?
An eGFR of 120 mL/min/1.73 m² is usually not a reason to worry in a healthy younger adult with stable creatinine, normal blood pressure, and urine ACR below 30 mg/g. The result deserves more context if it is new, if creatinine is unusually low below about 0.6 mg/dL, or if diabetes, pregnancy, weight loss, or albuminuria is present. A repeat test in 1-3 months under ordinary hydration is a reasonable first step for most asymptomatic people. Cystatin C can help when muscle mass makes creatinine-based eGFR unreliable.
Is high eGFR a sign of diabetes?
High eGFR can be an early diabetes-related hyperfiltration pattern, but it cannot diagnose diabetes on its own. Diabetes is diagnosed with confirmed HbA1c of 6.5% or higher, fasting plasma glucose of 126 mg/dL or higher, or other accepted glucose criteria in the right clinical setting. High eGFR is more concerning when it occurs with HbA1c elevation, fasting hyperglycaemia, blood pressure above 140/90 mmHg, or urine ACR of 30 mg/g or higher. Normal glucose and normal urine albumin make diabetes-related kidney stress less likely.
What test confirms whether a high eGFR is accurate?
Cystatin C-based eGFR, ideally combined with creatinine-based eGFR, is the usual confirmation when a high eGFR may be distorted by low or unusual muscle mass. Creatinine eGFR can overestimate filtration in frailty, muscle wasting, liver disease, amputation, and major weight loss. A first-morning urine ACR below 30 mg/g adds reassurance that the kidney filtration barrier is intact. Directly measured GFR is reserved for selected cases such as living donor assessment or high-stakes medication dosing.
Get AI-Powered Blood Test Analysis Today
Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.
📚 Referenced Research Publications
Klein, T., Mitchell, S., & Weber, H. (2026). Urobilinogen in Urine Test: Complete Urinalysis Guide 2026. Zenodo. https://doi.org/10.5281/zenodo.18226379. ResearchGate: https://www.researchgate.net/search.Search.html?query=Urobilinogen%20in%20Urine%20Test%20Complete%20Urinalysis%20Guide%202026. Academia.edu: https://www.academia.edu/search?q=Urobilinogen%20in%20Urine%20Test%20Complete%20Urinalysis%20Guide%202026. Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). Iron Studies Guide: TIBC, Iron Saturation & Binding Capacity. Zenodo. https://doi.org/10.5281/zenodo.18248745. ResearchGate: https://www.researchgate.net/search.Search.html?query=Iron%20Studies%20Guide%20TIBC%20Iron%20Saturation%20Binding%20Capacity. Academia.edu: https://www.academia.edu/search?q=Iron%20Studies%20Guide%20TIBC%20Iron%20Saturation%20Binding%20Capacity. Kantesti AI Medical Research.
📖 External Medical References
📖 Continue Reading
Explore more expert-reviewed medical guides from the Kantesti medical team:

Anti-Inflammatory Foods List: 20 Evidence-Based Picks
Nutrition Evidence Lab Interpretation 2026 Update Patient-Friendly The best choices are ordinary foods eaten repeatedly, not expensive powders...
Read Article →
Omega-3 for Triglycerides: Dose, Timing and Safety
Lipid Health Lab Interpretation 2026 Update Patient-Friendly Prescription-strength omega-3 can lower triglycerides meaningfully, but a typical fish-oil capsule...
Read Article →
Subclinical Hypothyroidism: Treat, Test, or Monitor?
Thyroid Health Lab Interpretation 2026 Update Patient-Friendly A mildly raised TSH with normal free T4 usually merits confirmation...
Read Article →
Undigested Food in Stool: Normal Causes and Warning Signs
Digestive Health Lab Interpretation 2026 Update Patient-Friendly Visible food particles are usually a digestion-speed or food-structure issue, not...
Read Article →
Bacteria in Urine Without Symptoms: When to Treat
Urine Testing Clinical Interpretation 2026 Update Patient-Friendly A positive urine culture does not automatically mean a urinary tract...
Read Article →
High Gastrin Levels: PPI Effects and Follow-Up
Gastroenterology Lab Interpretation 2026 Update Patient-Friendly High gastrin levels are often caused by proton-pump inhibitors (PPIs), which reduce...
Read Article →Discover all our health guides and AI-powered blood test analysis tools at kantesti.net
⚕️ Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.
E-E-A-T Trust Signals
Experience
Physician-led clinical review of lab interpretation workflows.
Expertise
Laboratory medicine focus on how biomarkers behave in clinical context.
Authoritativeness
Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.
Trustworthiness
Evidence-based interpretation with clear follow-up pathways to reduce alarm.